0000899866-14-000204.txt : 20140918
0000899866-14-000204.hdr.sgml : 20140918
20140918173355
ACCESSION NUMBER: 0000899866-14-000204
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140916
FILED AS OF DATE: 20140918
DATE AS OF CHANGE: 20140918
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALEXION PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000899866
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133648318
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 352 KNOTTER DRIVE
CITY: CHESHIRE
STATE: CT
ZIP: 06511
BUSINESS PHONE: 2037761790
MAIL ADDRESS:
STREET 1: 352 KNOTTER DRIVE
CITY: CHESHIRE
STATE: CT
ZIP: 06511
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BELL LEONARD
CENTRAL INDEX KEY: 0001231949
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-27756
FILM NUMBER: 141110652
MAIL ADDRESS:
STREET 1: C/O ALEXION PHARMACEUTICALS INC
STREET 2: 352 KNOTTER DRIVE
CITY: CHESHIRE
STATE: CT
ZIP: 06410
4
1
wf-form4_141107602489819.xml
FORM 4
X0306
4
2014-09-16
0
0000899866
ALEXION PHARMACEUTICALS INC
ALXN
0001231949
BELL LEONARD
C/O ALEXION PHARMACEUTICALS INC
352 KNOTTER DRIVE
CHESHIRE
CT
06410
1
1
0
0
CEO
Common Stock, par value $.0001 per share
2014-09-16
4
M
0
32047
17.65
A
1053321
D
Common Stock, par value $.0001 per share
2014-09-16
4
S
0
12878
159.87
D
1040443
D
Common Stock, par value $.0001 per share
2014-09-16
4
S
0
19169
160.53
D
1021274
D
Common Stock, par value $.0001 per share
2014-09-18
4
S
0
12388
161.45
D
1008886
D
Option to Purchase Common Stock
17.65
2014-09-16
4
M
0
32047
0
D
2008-04-09
2018-01-09
Common Stock
32047.0
0
D
This transaction is made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $159.15 - $160.15. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $160.15 - $161.50. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
The sale of common stock reported by this Form 4 consists of Alexion common stock contributed by the reporting person to an exchange fund in exchange for shares of the exchange fund. The Alexion shares were valued at $161.45 per share for the purpose of determining the number of shares of the exchange fund issuable to the reporting person.
/s/ Michael Greco, Attorney-in-Fact
2014-09-18